8-K - CUMBERLAND PHARMACEUTICALS INC - 1.01 / 7.01 / 8.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001104659-26-047335

Filing Date: 2026-04-23

Accepted: 2026-04-23 09:01:32

Documents: 15

Period of Report: 2026-04-22

Items: Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

CUMBERLAND PHARMACEUTICALS INC (Filer) CIK : 0001087294 (see all company filings) EIN. : 621765329 | State of Incorp.: TN | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 26885830 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | FORM 8-K | tm2611622d1_8k.htm iXBRL | 8-K

2 | EXHIBIT 2.1 | tm2611622d1_ex2-1.htm | EX-2.1

3 | EXHIBIT 10.1 | tm2611622d1_ex10-1.htm | EX-10.1

4 | EXHIBIT 99.1 | tm2611622d1_ex99-1.htm | EX-99.1